Acrivon Therapeutics Inc
Company Profile
Business description
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company’s pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
Contact
480 Arsenal Way
Suite 100
Watertown MA 02472
USAT: +1 617 207-8979
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
61
Stocks News & Analysis
video
Now the dust has settled, a mini earnings wrap
stocks
This moated ASX stock is swimming in cash
video
ASX shares to own forever
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,323.50 | 30.40 | 0.37% |
| CAC 40 | 7,465.25 | 30.18 | 0.41% |
| DAX 40 | 18,699.40 | 181.01 | 0.98% |
| Dow JONES (US) | 41,393.78 | 297.01 | 0.72% |
| FTSE 100 | 8,273.09 | 32.12 | 0.39% |
| HKSE | 17,369.09 | 128.70 | 0.75% |
| NASDAQ | 17,683.98 | 114.30 | 0.65% |
| Nikkei 225 | 36,581.76 | 251.51 | -0.68% |
| NZX 50 Index | 12,832.55 | 12.27 | 0.10% |
| S&P 500 | 5,626.02 | 30.26 | 0.54% |
| S&P/ASX 200 | 8,099.90 | 24.20 | 0.30% |
| SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Red 5 Ltd RED | 0.33 | 0.03 | 8.20% |
| Latin Resources Ltd LRS | 0.20 | 0.01 | 2.56% |
| Pilbara Minerals Ltd PLS | 2.90 | 0.02 | 0.69% |
| Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | 0.00% |
| Telstra Group Ltd TLS | 3.96 | 0.00 | 0.00% |
| Appen Ltd APX | 1.55 | 0.05 | 3.33% |
| Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
| South32 Ltd S32 | 3.19 | 0.11 | 3.57% |
| Fortescue Ltd FMG | 17.50 | 0.84 | 5.04% |
| Resolute Mining Ltd RSG | 0.74 | 0.04 | 5.76% |